Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02458820 · ClinicalTrials.gov registry record · NA
Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02458820 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 18 participants.
The verdict
NCT02458820, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Non-convulsive seizures (NCS) following cardiac arrest are common and are associated with worse neurologic outcomes and increased mortality. More prolonged seizures (status epilepticus) are associated with worse outcomes. Earlier diagnosis and treatment of seizures may lead to earlier termination of seizures and decreased seizure burden. This study will evaluate whether bedside intensive care unit (ICU) provider interpretation of a type of EEG called DSA EEG can be used by non-neurologists to diagnosis seizures more rapidly than continuous EEG's routinely read by neurologists.
Interventions
- PROCEDURE DSA EEG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02458820
The ClinicalTrials.gov registry entry for NCT02458820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DSA EEG is the first listed.
NCT02458820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02458820 about?
NCT02458820 is a clinical study titled "Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest". Non-convulsive seizures (NCS) following cardiac arrest are common and are associated with worse neurologic outcomes and increased mortality. More prolonged seizures (status epilepticus) are associated with worse outcomes. Earlier diagnosis and treatment of seizures may lead to earlier termination of...
What is the current status of trial NCT02458820?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-06. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02458820?
The interventions under investigation include: DSA EEG (PROCEDURE).
Who is sponsoring clinical trial NCT02458820?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.